Urell and Pregnancy

NCT01818180 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2013-03-26

No results posted yet for this study

Summary

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).

Conditions

  • Urinary Tract Infection (UTI)

Interventions

DIETARY_SUPPLEMENT

URELL

OTHER

Placebo

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Jean Marc AYOUBI, PU-PH · Hôpital FOCH 40, rue Worth 92150 Suresnes

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01818180 on ClinicalTrials.gov